These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28430373)

  • 1. A five-miRNA expression signature predicts survival in hepatocellular carcinoma.
    Liu G; Wang H; Fu JD; Liu JY; Yan AG; Guan YY
    APMIS; 2017 Jul; 125(7):614-622. PubMed ID: 28430373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
    Zhang J; Chong CC; Chen GG; Lai PB
    PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients.
    Wang S; Zhang JH; Wang H; Yang L; Hong S; Yu B; Guo JC; Liu J; Zhu YB
    J Cell Physiol; 2019 Jul; 234(7):11610-11619. PubMed ID: 30480822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
    Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y
    J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    Zeng Y; Wang KX; Xu H; Hong Y
    J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].
    Chen Q; Qiu XQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):522-527. PubMed ID: 28468075
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.
    Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY
    Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA.
    Zhang J; Fan J; Zhou C; Qi Y
    BMC Gastroenterol; 2017 Jun; 17(1):81. PubMed ID: 28637446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
    Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
    Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
    Meng T; Wang Q; Yang Y; Ren Y; Shi Y
    Front Genet; 2022; 13():825261. PubMed ID: 35495130
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.
    Ma C; Zhang W; Wu Q; Liu Y; Wang C; Lao G; Yang L; Liu P
    PLoS One; 2018; 13(3):e0193625. PubMed ID: 29513728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.
    Nagy Á; Lánczky A; Menyhárt O; Győrffy B
    Sci Rep; 2018 Jun; 8(1):9227. PubMed ID: 29907753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
    Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
    BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.
    Zhi F; Chen X; Wang S; Xia X; Shi Y; Guan W; Shao N; Qu H; Yang C; Zhang Y; Wang Q; Wang R; Zen K; Zhang CY; Zhang J; Yang Y
    Eur J Cancer; 2010 Jun; 46(9):1640-9. PubMed ID: 20219352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.